Jan P. van Meerbeeck
- Pulmonary and Respiratory Medicine top 0.05%
- Lung Cancer Treatments and Mutations 132
- Lung Cancer Diagnosis and Treatment 126
- Occupational and environmental lung diseases 109
- Pleural and Pulmonary Diseases 80
- Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis 40
- Medical Imaging and Pathology Studies 34
- Oncology top 0.2%
- Lung Cancer Research Studies 78
- Otorhinolaryngology top 1%
- Cancer Research top 1%
-
- Neuroendocrine Tumor Research Advances 23
Jan P. van Meerbeeck
380 papers receiving 14.7k citations
Hit Papers
Peers
Comparison fields: 5 of 164
- Pulmonary and Respiratory Medicine 10.6k
- Oncology 5.5k
- Otorhinolaryngology 424
- Cancer Research 1.3k
- Radiology, Nuclear Medicine and Imaging 1.9k
Countries citing papers authored by Jan P. van Meerbeeck
This map shows the geographic impact of Jan P. van Meerbeeck's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jan P. van Meerbeeck with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jan P. van Meerbeeck more than expected).
Fields of papers citing papers by Jan P. van Meerbeeck
This network shows the impact of papers produced by Jan P. van Meerbeeck. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jan P. van Meerbeeck. The network helps show where Jan P. van Meerbeeck may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Jan P. van Meerbeeck, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2023 | 7 | |
| 3 | 2022 | 3 | |
| 4 | 2022 | 3 | |
| 5 | 2022 | 5 | |
| 6 | 2020 | 6 | |
| 7 | 2019 | 74 | |
| 8 | 2019 | 35 | |
| 9 | 2018 | 18 | |
| 10 | Radiologic-Pathologic Correlation in Lung Cancer Presenting as a Subsolid Nodule: Room for Improvement? | 2017 | 2 |
| 11 | 2016 | 1 | |
| 12 | 2016 | 2 | |
| 13 | Second opinion for thoracic cancer and its impact on diagnosis and treatment strategy: a single institutional series | 2013 | 2 |
| 14 | Resistance training in patients with radically treated respiratory cancer: mature results of a multi-centre randomised phase 3 trial (REINFORCE) | 2013 | 3 |
| 15 | Effect of radical treatment on exercise capacity and muscle force in patients with intrathoracic cancer | 2012 | 0 |
| 16 | Validation of soluble mesothelin: design and preliminary results of a Belgian multicentric observational study | 2009 | 1 |
| 17 | Non-small cell lung cancer and health-related quality of life (HRQOL): Is baseline HRQOL of prognostic value for survival? | 2005 | 1 |
| 18 | Bronchuscarcinoom in Vlaanderen. | 1995 | 1 |
| 19 | 1994 | 6 | |
| 20 | Mesothelioma, current insights | 1994 | 3 |
About Jan P. van Meerbeeck
Jan P. van Meerbeeck is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Otorhinolaryngology, having authored 389 papers that have together received 15.1k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (132 papers), Lung Cancer Diagnosis and Treatment (126 papers), Occupational and environmental lung diseases (109 papers), Pleural and Pulmonary Diseases (80 papers), Lung Cancer Research Studies (78 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (40 papers), Medical Imaging and Pathology Studies (34 papers) and Neuroendocrine Tumor Research Advances (23 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (10.6k citations), Oncology (5.5k citations) and Otorhinolaryngology (424 citations). Jan P. van Meerbeeck has collaborated with scholars based in Belgium, Netherlands and United States. Frequent co-authors include Dean A. Fennell, Giuseppe Giaccone, Paul Baas, C. Debruyne, Walter Weder, Paul Van Schil, Peter Goldstraw, Lucio Crinò, Veerle Surmont and Kari Chansky. Their work appears in journals such as Journal of Clinical Oncology, Lung Cancer, Journal of Thoracic Oncology, Annals of Oncology and European Respiratory Journal.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.